| Efficient inhibition of protein aggregation, disintegration of aggregates, and lowering of cytotoxicity by green tea polyphenol-based self-assembled polymer nanoparticles K Debnath, S Shekhar, V Kumar, NR Jana, NR Jana ACS applied materials & interfaces 8 (31), 20309-20318, 2016 | 111 | 2016 |
| Glycogen synthase protects neurons from cytotoxicity of mutant huntingtin by enhancing the autophagy flux A Rai, PK Singh, V Singh, V Kumar, R Mishra, AK Thakur, A Mahadevan, ... Cell death & disease 9 (2), 201, 2018 | 31 | 2018 |
| Azadiradione restores protein quality control and ameliorates the disease pathogenesis in a mouse model of Huntington’s disease BK Singh, N Vatsa, VK Nelson, V Kumar, SS Kumar, SC Mandal, M Pal, ... Molecular neurobiology 55, 6337-6346, 2018 | 30 | 2018 |
| Hyperexcitability and homeostasis in fragile X syndrome X Liu, V Kumar, NP Tsai, BD Auerbach Frontiers in Molecular Neuroscience 14, 805929, 2022 | 28 | 2022 |
| Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer’s disease BK Singh, N Vatsa, V Kumar, S Shekhar, A Sharma, NR Jana Human Molecular Genetics 26 (20), 4042-4054, 2017 | 27 | 2017 |
| Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome I Jamal, V Kumar, N Vatsa, S Shekhar, BK Singh, A Sharma, NR Jana Neurobiology of Disease 105, 99-108, 2017 | 27 | 2017 |
| Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathology M Maheshwari, S Shekhar, BK Singh, I Jamal, N Vatsa, V Kumar, ... Human molecular genetics 23 (23), 6235-6245, 2014 | 26 | 2014 |
| Withaferin A Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington's Disease NRJ Tripti Joshi, Vipendra Kumar, Elena V Kaznacheyeva Molecular Neurobiology, 2021 | 20 | 2021 |
| Down-regulation of miRNA-708 promotes aberrant calcium signaling by targeting neuronatin in a mouse model of angelman syndrome N Vatsa, V Kumar, BK Singh, SS Kumar, A Sharma, NR Jana Frontiers in Molecular Neuroscience 12, 35, 2019 | 18 | 2019 |
| Environmental enrichment improves behavioral abnormalities in a mouse model of Angelman syndrome I Jamal, V Kumar, N Vatsa, BK Singh, S Shekhar, A Sharma, NR Jana Molecular neurobiology 54, 5319-5326, 2017 | 13 | 2017 |
| Simvastatin restores HDAC1/2 activity and improves behavioral deficits in Angelman syndrome model mouse V Kumar, T Joshi, N Vatsa, BK Singh, NR Jana Frontiers in Molecular Neuroscience 12, 289, 2019 | 12 | 2019 |
| Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington’s disease S Shekhar, N Vatsa, V Kumar, BK Singh, I Jamal, A Sharma, NR Jana Human Molecular Genetics 26 (2), 420-429, 2017 | 7 | 2017 |
| mGluR7 allosteric modulator AMN082 corrects protein synthesis and pathological phenotypes in FXS V Kumar, KY Lee, A Acharya, MS Babik, CA Christian-Hinman, ... EMBO Molecular Medicine, 1-17, 2024 | | 2024 |
| Role of simvastatin in restoration of behavioral and synaptic deficits in Angelman syndrome mouse model V Kumar, T Joshi, NR Jana IBRO Reports 6, S248, 2019 | | 2019 |
| Topotecan, a Topoisomerase-1 Inhibitor, Retards the Disease Pathogenesis in a Mouse Model of Huntington's Disease SS Kumar, N Vatsa, V Kumar, BK Singh, I Jamal, A Sharma, NR Jana NEUROTHERAPEUTICS 15 (1), 252-252, 2018 | | 2018 |
| Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1dE9 mouse model of Alzheimer’s disease BK Singh, N Vatsa, V Kumar, S Shekhar, A Sharma, NR Jana | | |
Nihar JanaDepartment of Bioscience and Biotechnology, Indian Institute of Technology, KharagpurVerified email at iitkgp.ac.in
